Clinical Study
Radiomic Profiling of Head and Neck Cancer: 18F-FDG PET Texture Analysis as Predictor of Patient Survival
Table 1
Patients’ clinical and demographic data.
| | Number of patients (%) |
| N | 90 | Mean age (range) | 60 (22–87) | ≥60 years | 52 (58%) | <60 years | 38 (42%) |
| Gender | | Male | 68 (75%) | Female | 22 (15%) |
| Primary site | | Oral cavity | 4 (4%) | Oropharynx | 49 (55%) | Hypopharynx | 10 (10%) | Nasopharynx | 13 (15%) | Larynx | 14 (16%) |
| Clinical T stage | | T1 | 15 (17%) | T2 | 30 (35%) | T3 | 29 (33%) | T4 | 13 (15%) |
| Clinical N stage | | N0 | 5 (5%) | N1 | 21 (24%) | N2 | 59 (66%) | N3 | 5 (5%) |
| Clinical stage | | III | 32 (35%) | IV | 58 (65%) |
| Patient cohort after follow-up (PFS) | | NED | 62 (69%) | RD | 28 (31%) |
| Patient cohort after follow-up (OS) | | Alive | 65 (72%) | Dead | 25 (28%) |
|
|